Seguimiento del periodo inmediato post-autotrasplante de células progenitoras hematopoyéticas / Follow-up of immediate period of post-autologous hematopoietic progenitor cells transplant

Introducción: el objetivo de este estudio fue describir el comportamiento clínico y de laboratorio presentado en autotrasplante de células progenitoras hematopoyéticas en un grupo de pacientes del Hospital Militar Central en el periodo de enero 2007 a octubre de 2010. Material y métodos: es un estudio descriptivo retrospectivo a través de la revisión de las historias clínicas de estos pacientes obteniendo la información sobre tiempo de alta pos trasplante, requerimiento transfusional, periodo aplásico (neutropenia absoluta, trombocitopenia severa, anemia severa y presentación de neutropenia febril), número de células madre trasplantadas, fuente y criopreservación o no. Los resultados de las diferentes variables por medir fueron tabulados y almacenados en una base para su posterior análisis descriptivo univariado cualitativo y cuantitativo. Resultados: todos los pacientes injertaron adecuadamente. El injerto de neutrófilos ocurrió entre 11-23 días, con una media de 14.44; el injerto de plaquetas ocurrió entre 13-25 días, con una media de 16.33, y la duración de la neutropenia absoluta fue de 5-14 días, con una media de 7.28. Conclusiones: la recuperación de los pacientes fue similar a lo descrito en la literatura internacional. (Acta Med Colomb 2012; 37: 172-176).

Introduction: the aim of this study was to describe the clinical and laboratory performance in autologous transplants of hematopoietic progenitor cells in a group of patients in the Hospital Militar Central in the period january 2007 to october 2010. Material and methods: we performed a retrospective descriptive study by reviewing the medical records of these patients in regard to the time of discharge from hospital after transplantation, transfusion requirement, aplastic period (absolute neutropenia, severe thrombocytopenia, severe anemia and febrile neutropenia presentation ), number of transplanted stem cells, source, and whether there was or not cryopreservation. The results of the different variables measured were tabulated and stored in a database for later univariate descriptive qualitative and quantitative analysis. Results: all patients grafts functioned properly. Neutrophil engraftment occurred between 11-23 days, with a mean of 14.44, platelet engraftment occurred between 13-25 days, with a mean of 16.33, and the absolute duration of neutropenia was 5-14 days, with a median of 7.28. Conclusions: the recovery of patients was similar to that described in the international literature. (Acta Med Colomb 2012; 37: 172-176).

Treatment of a Case of Malignant Lymphoma by Autologous Peripheral Blood Stem Cell Transplantation / 中国输血杂志

A success in reconstruction of the hematopoietic function of marrow in a case of malignant lymphoma attained by autologous peripheral blood stem cell transplantation after the ultra-high dose chemoradiotherapy was reported. The platelet count of patient was increased to over 20 ? 109/L at the eighth day after PBSC transplantation and was recovered to over 50?109/L at the tenth day after PBSC transplantation. The white blood cell count was increased to over 0. 5?109/ L at the ninth day after PBSC transplantation. The pelvic CT-graphy showed reduction in size of the tumor. And then the patient was outhospitalized due to remission,having been surviving for more than 6 months with routine follow-up. It was suggested that the autologous peripheral blood stem cell transplantation could be a safe and effective suplement therapy for radical cure of malignant tumor.